Bajaj Healthcare

29
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
419.65
-4.55 (-1.07%)
BSENSE

Dec 05

BSE+NSE Vol: 38.96 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024

Compare Profit and Loss Results of Bajaj Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
542.00
407.00
135.00
33.17%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
542.00
407.00
135.00
33.17%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
-2.00
-18.00
-900.00%
Raw Materials Consumed
307.00
197.00
110.00
55.84%
Power & Fuel Cost
22.00
11.00
11.00
100.00%
Employee Cost
57.00
57.00
0.00
0.00%
Operating Expenses
63.00
24.00
39.00
162.50%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
24.00
-18.00
-75.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
2.00
4.00
200.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
460.00
333.00
127.00
38.14%
Operating Profit (PBDIT) excl Other Income
82.00
74.00
8.00
10.81%
Other Income
19.00
20.00
-1.00
-5.00%
Operating Profit (PBDIT)
101.00
94.00
7.00
7.45%
Interest
27.00
10.00
17.00
170.00%
Profit before Depriciation and Tax
73.00
83.00
-10.00
-12.05%
Depreciation
27.00
12.00
15.00
125.00%
Profit Before Taxation & Exceptional Items
46.00
70.00
-24.00
-34.29%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
70.00
-24.00
-34.29%
Provision for Tax
3.00
23.00
-20.00
-86.96%
Profit After Tax
42.00
47.00
-5.00
-10.64%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
267.00
145.00
122.00
84.14%
Profit Available for appropriations
310.00
193.00
117.00
60.62%
Appropriations
310.00
193.00
117.00
60.62%
Equity Dividend (%)
20%
10%
10.00
Earnings Per Share
13.29
1.41
11.88
842.55%
Profit And Loss - Net Sales
Net Sales 542.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024

Profit And Loss - Interest
Interest 27.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 42.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024